SOURCE: Transfer Technology International Corporation

Transfer Technology International Corporation

October 19, 2010 08:30 ET

Transfer Technology International Corp. Announces Overview and Corporate Update

WESLEY CHAPEL, FL--(Marketwire - October 19, 2010) -  (PINKSHEETS: TTIN) "There have been many exciting developments in 2010. It is very important to for us to keep our valued stockholders informed as well as the investment community as we execute on our business plan and goals for the future," states Christoph Trina, Chairman and CEO.

"In what turned out to be our toughest period of time in dealing with our economy and seeking our private funding goals we were able to achieve and execute on many important items and milestones nonetheless. I truly believe the worst is now behind us as we execute on all cylinders in this last quarter and into 2011 calendar year going forward," Trina commented. He also stated, "I'm extremely proud of our accomplishments thus far and felt it to be of extreme importance to share them with our shareholders and the investment and finance community at this particular time. Listed are what I consider to be key achievements or milestones reached thus far in 2010."

  • RETAINED PRESTIGOUS AUDITING FIRM OF FRIEDMAN, LLP FOR SEC AUDIT REVIEW
  • CUT CORPORATE OVERHEAD BY AS MUCH AS 40%
  • FILED 15C-211 WITH FINRA FOR OBTAINING BULLETIN BOARD TRADING LISTING
  • LAUNCHED WHOLLY OWNED AND REVENUE PRODUCING SUBSIDIARY, X-TERMINATE, INC
  • COMPLETED A VERY SUCCESSFUL ONE-YEAR GREEN-HOUSE STUDY FOR ECO-AVENGER CANKER KILL PRODUCT SHOWING GREAT EFFICACY TEST RESULTS
  • INCREASED WEBSITE PRESENCE BY SEO AWARENESS AND REVAMPING OF WEBSITES
  • COMMENCED 6- MONTH FIELD STUDY WITH ECO-AVENGER CANKER KILL WITH A SOUTHEASTERN BASED PROMINENT UNIVERSITY AT NO COST TO TTI
  • INCREASED SALES AND MARKETING PRESENCE TO TAKE ADVANTAGE OF BED BUG HYSTERIA AND MEDIA ATTENTION
  • PRODUCING REVENUES IN OUR SUBSIDIARY ORGANIC PRODUCTS INT'L
  • CONTINUED OUR EFFORTS TO OBTAIN EPA LABEL FOR ECO-AVENGER CANKER KILL PRODUCT
  • OBTAINED FULLY REPORTING STATUS IN ALL SEC FILINGS
  • CONVERTED 600 THOUSAND OF DEBT TO EQUITY TO BOLSTER OUR BALANCE SHEET

Trina ended by stating, "I believe that much was accomplished during the most tumultuous economy in recent history over the last 10 months and we raised the needed capital to stay the course and as I stated before the worst is now behind us. We have laid the foundation with these and many more achievements to have a successful and profitable 2011 as I turn my efforts in the fourth quarter to raising additional needed financing and improving shareholder valuation."

Disclaimer and Forward Looking Statements -- The information contained herein regarding risks and uncertainties, which may differ materially from those set forth in these statements, in addition to the economic, competitive, governmental, technological and other factors, constitutes a "forward-looking statement" within the meaning of Section 27A of The Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbors created thereby. While the company believes that the assumptions underlying such forward-looking information are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward- looking information will prove to be accurate. Accordingly, there may be differences between the actual results and the predicted results, and actual results may be materially higher or lower than those indicated in the forward-looking information contained herein.

Contact Information

  • Contact for Investors:

    Mr. Christoph A. Trina
    Chairman and CEO
    813-388-6891